Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Non-cash Items (2020 - 2026)

Oric Pharmaceuticals filings provide 7 years of Non-cash Items readings, the most recent being $99.6 million for Q1 2026.

  • Quarterly Non-cash Items rose 1329.84% to $99.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $99.6 million through Mar 2026, up 1329.84% year-over-year, with the annual reading at $30.7 million for FY2025, 1.23% down from the prior year.
  • Non-cash Items hit $99.6 million in Q1 2026 for Oric Pharmaceuticals, up from $30.7 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $99.6 million in Q1 2026 and bottomed at $1.7 million in Q3 2022.
  • Average Non-cash Items over 5 years is $23.7 million, with a median of $12.9 million recorded in 2023.
  • The largest annual shift saw Non-cash Items tumbled 96.5% in 2022 before it soared 1375.08% in 2025.
  • Oric Pharmaceuticals' Non-cash Items stood at $14.1 million in 2022, then soared by 194.75% to $41.7 million in 2023, then fell by 25.37% to $31.1 million in 2024, then dropped by 1.23% to $30.7 million in 2025, then skyrocketed by 224.1% to $99.6 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Non-cash Items are $99.6 million (Q1 2026), $30.7 million (Q4 2025), and $80.3 million (Q3 2025).